Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.

Göçeroğlu A, Grenmyr E, Berden AE, Hagen EC, Bunch D, Sommarin Y, Bruijn JA, Bajema IM, Wieslander J.

PLoS One. 2018 Nov 12;13(11):e0207064. doi: 10.1371/journal.pone.0207064. eCollection 2018.

2.

Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.

Tati R, Kristoffersson AC, Manea Hedström M, Mörgelin M, Wieslander J, van Kooten C, Karpman D.

EBioMedicine. 2017 Feb;16:302-311. doi: 10.1016/j.ebiom.2017.01.032. Epub 2017 Jan 24.

3.

Development of a mobile radioxenon processing system for on-site inspections and the deployment in IFE14.

Zhou C, Zhou G, Feng S, Huang D, Zhao X, Wieslander JSE, Khrustalev K, Yu X, Cheng Z, Wu R, Zou R.

J Environ Radioact. 2016 Oct;162-163:310-318. doi: 10.1016/j.jenvrad.2016.06.003. Epub 2016 Jun 20.

PMID:
27323211
4.

Calibration of low-level beta-gamma coincidence detector systems for xenon isotope detection.

Khrustalev K, Wieslander JSE, Auer M, Gheddou A.

Appl Radiat Isot. 2016 Mar;109:418-424. doi: 10.1016/j.apradiso.2015.11.032. Epub 2015 Dec 2.

PMID:
26702548
5.

European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.

Würzner R, Tedesco F, Garred P, Mollnes TE, Truedsson L, Turner MW, Sommarin Y, Wieslander J, Sim RB.

Mol Immunol. 2015 Nov;68(1):63-6. doi: 10.1016/j.molimm.2015.05.003. Epub 2015 May 23. Review.

PMID:
26006049
6.

A Case of Alport Syndrome with Posttransplant Antiglomerular Basement Membrane Disease despite Negative Antiglomerular Basement Membrane Antibodies by EIA Treated with Plasmapheresis and Intravenous Immunoglobulin.

Armstead SI, Hellmark T, Wieslander J, Zhou XJ, Saxena R, Rajora N.

Case Rep Transplant. 2013;2013:164016. doi: 10.1155/2013/164016. Epub 2013 Dec 2.

7.

Evaluation of complement function by ELISA.

Roos A, Wieslander J.

Methods Mol Biol. 2014;1100:11-23. doi: 10.1007/978-1-62703-724-2_2.

PMID:
24218247
8.

Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.

Ohlsson S, Herlitz H, Lundberg S, Selga D, Mölne J, Wieslander J, Segelmark M.

Am J Kidney Dis. 2014 Feb;63(2):289-93. doi: 10.1053/j.ajkd.2013.08.032. Epub 2013 Nov 1.

PMID:
24189476
9.

Goodpasture's syndrome with concomitant immune complex mixed membranous and proliferative glomerulonephritis.

Jurcić V, Vizjak A, Rigler AA, Jeruc J, Wieslander J, Ferluga D.

Clin Nephrol. 2014 Mar;81(3):216-23. doi: 10.5414/CN107454.

PMID:
23320965
10.

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies.

Segelmark M, Dahlberg P, Wieslander J.

Clin Kidney J. 2012 Dec;5(6):549-51. doi: 10.1093/ckj/sfs098. Epub 2012 Oct 5.

11.

Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.

Aanaes K, Rasmussen N, Pressler T, Segelmark M, Johansen HK, Lindberg U, Høiby N, Carlsson M, Wieslander J, Buchwald C.

Scand J Immunol. 2012 Dec;76(6):573-9. doi: 10.1111/j.1365-3083.2012.02775.x.

12.

Breastfeeding from mammary glands covered at the beginning of breast development by an expanded abdominal flap.

Wieslander JB.

Plast Reconstr Surg. 2012 Apr;129(4):754e-6e. doi: 10.1097/PRS.0b013e318245e838. No abstract available.

PMID:
22456409
13.

Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG.

N Engl J Med. 2010 Jul 22;363(4):343-54. doi: 10.1056/NEJMoa0910500.

14.

Angular distribution of proton leakage from a fusion plasma using ultra low-level gamma-ray spectrometry.

de Orduña RG, Hult M, Bonheure G, Arnold D, Dombrowski H, Laubenstein M, Wieslander JS, Vidmar T, Vermaercke P.

Appl Radiat Isot. 2010 Jul-Aug;68(7-8):1226-30. doi: 10.1016/j.apradiso.2009.11.019. Epub 2009 Nov 13.

PMID:
19962906
15.

Validation of a method for neutron dosimetry and spectrometry using neutron activation of metal discs.

Wieslander JS, Lövestam G, Hult M, Fessler A, Gasparro J, Kockerols P.

Radiat Prot Dosimetry. 2010 Mar;138(3):205-12. doi: 10.1093/rpd/ncp258. Epub 2009 Nov 7.

PMID:
19897859
16.

Smallest known Q value of any nuclear decay: the rare beta;{-} decay of ;{115}In(9/2;{+}) --> ;{115}Sn(3/2;{+}).

Wieslander JS, Suhonen J, Eronen T, Hult M, Elomaa VV, Jokinen A, Marissens G, Misiaszek M, Mustonen MT, Rahaman S, Weber C, Aystö J.

Phys Rev Lett. 2009 Sep 18;103(12):122501. Epub 2009 Sep 16.

PMID:
19792426
17.

Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.

Ceribelli A, Andreoli L, Cavazzana I, Franceschini F, Radice A, Rimoldi L, Sinico RA, Carlsson M, Wieslander J, Tincani A.

Ann N Y Acad Sci. 2009 Sep;1173:427-34. doi: 10.1111/j.1749-6632.2009.04921.x.

PMID:
19758182
18.

Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.

Kahn R, Hellmark T, Leeb-Lundberg LM, Akbari N, Todiras M, Olofsson T, Wieslander J, Christensson A, Westman K, Bader M, Müller-Esterl W, Karpman D.

J Immunol. 2009 Jun 15;182(12):7906-15. doi: 10.4049/jimmunol.0803624.

19.

Search for the radioactivity of 180mTa using an underground HPGe sandwich spectrometer.

Hult M, Wieslander JS, Marissens G, Gasparro J, Wätjen U, Misiaszek M.

Appl Radiat Isot. 2009 May;67(5):918-21. doi: 10.1016/j.apradiso.2009.01.057. Epub 2009 Jan 24.

PMID:
19246206
20.

The Sandwich spectrometer for ultra low-level gamma-ray spectrometry.

Wieslander JS, Hult M, Gasparro J, Marissens G, Misiaszek M, Preusse W.

Appl Radiat Isot. 2009 May;67(5):731-5. doi: 10.1016/j.apradiso.2009.01.026. Epub 2009 Jan 23.

PMID:
19246202
21.

Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.

Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.

Clin Immunol. 2008 Sep;128(3):415-26. doi: 10.1016/j.clim.2008.04.012. Epub 2008 Jun 20.

PMID:
18571472
22.

Depressed activation of the lectin pathway of complement in hereditary angioedema.

Varga L, Széplaki G, Laki J, Kocsis A, Kristóf K, Gál P, Bajtay Z, Wieslander J, Daha MR, Garred P, Madsen HO, Füst G, Farkas H.

Clin Exp Immunol. 2008 Jul;153(1):68-74. doi: 10.1111/j.1365-2249.2008.03671.x. Epub 2008 May 5.

23.

Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.

Carlsson M, Eriksson L, Pressler T, Kornfält R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M.

J Cyst Fibros. 2007 May;6(3):228-33. Epub 2006 Dec 12.

24.

Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease.

Sárdy M, Csikós M, Geisen C, Preisz K, Kornseé Z, Tomsits E, Töx U, Hunzelmann N, Wieslander J, Kárpáti S, Paulsson M, Smyth N.

Clin Chim Acta. 2007 Feb;376(1-2):126-35. Epub 2006 Aug 14.

PMID:
16987503
25.

Molecular mapping of the Goodpasture's epitope for glomerulonephritis.

Bolton WK, Chen L, Hellmark T, Fox J, Wieslander J.

Trans Am Clin Climatol Assoc. 2005;116:229-36; discussion 237-8.

26.

Alport syndrome in southern Sweden.

Persson U, Hertz JM, Wieslander J, Segelmark M.

Clin Nephrol. 2005 Aug;64(2):85-90.

PMID:
16114783
27.

Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.

Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW.

J Am Soc Nephrol. 2005 Sep;16(9):2657-66. Epub 2005 Jul 27.

28.

Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.

Ohlsson S, Hellmark T, Pieters K, Sturfelt G, Wieslander J, Segelmark M.

Clin Exp Immunol. 2005 Jul;141(1):174-82.

29.

Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.

Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR.

J Immunol Methods. 2005 Jan;296(1-2):187-98. Epub 2004 Dec 15.

PMID:
15680163
30.
31.

Patients with Goodpasture's disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain.

Persson U, Hertz JM, Carlsson M, Hellmark T, Juncker I, Wieslander J, Segelmark M.

Nephrol Dial Transplant. 2004 Aug;19(8):2030-5. Epub 2004 Jun 15.

PMID:
15199166
32.

Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.

Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S95-100.

PMID:
14740434
33.

Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.

Selga D, Segelmark M, Wieslander J, Gunnarsson L, Hellmark T.

Clin Exp Immunol. 2004 Jan;135(1):164-72.

34.

Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.

Chen L, Hellmark T, Wieslander J, Bolton WK.

Kidney Int. 2003 Dec;64(6):2108-20.

35.

Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.

Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL.

Rheumatology (Oxford). 2004 Feb;43(2):174-80. Epub 2003 Oct 29.

PMID:
14585921
36.

X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.

Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC.

J Am Soc Nephrol. 2003 Oct;14(10):2603-10.

37.

Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.

Hellmark T, Chen L, Ohlsson S, Wieslander J, Bolton WK.

J Biol Chem. 2003 Nov 21;278(47):46516-22. Epub 2003 Sep 11.

38.
39.

Reconstruction with microvascular free flaps by visiting microsurgeons.

Lutz BS, Wieslander JB.

Scand J Plast Reconstr Surg Hand Surg. 2003;37(3):140-4.

PMID:
12841613
41.

Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.

Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J.

Clin Exp Immunol. 2003 Jan;131(1):190-6.

42.

[Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? ]

Bellisai F, Morozzi G, Bacarelli MR, Radice A, Sinico RA, Wieslander J, Sebastiani GD, Campanella V, Marcolongo R, Galeazzi M.

Reumatismo. 2001;53(1):33-39. Italian.

44.

Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.

Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J.

Mediators Inflamm. 2001 Dec;10(6):347-50.

45.

How and why should we detect ANCA?

Segelmark M, Westman K, Wieslander J.

Clin Exp Rheumatol. 2000 Sep-Oct;18(5):629-35. Review.

PMID:
11072609
46.

Molecular properties of the Goodpasture epitope.

Gunnarsson A, Hellmark T, Wieslander J.

J Biol Chem. 2000 Oct 6;275(40):30844-8.

48.

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC.

J Am Soc Nephrol. 2000 Apr;11(4):649-57.

49.
50.

The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis.

Elzouki AN, Eriksson S, Löfberg R, Nässberger L, Wieslander J, Lindgren S.

Inflamm Bowel Dis. 1999 Nov;5(4):246-52.

PMID:
10579117

Supplemental Content

Loading ...
Support Center